Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Genesen

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Western Journal of Medicine|December 1, 1994
Using the fax--concerns about patient confidentialityH M Sharp, L B Genesen, M Genesen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2007
A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancerJ P Micha, B H Goldstein, M A Rettenmaier, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Western Journal of Medicine|December 1, 1994
Using the fax--concerns about patient confidentialityH M Sharp, L B Genesen, M Genesen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2007
A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancerJ P Micha, B H Goldstein, M A Rettenmaier, et al.
Pageof 1